Funding for this research was provided by:
Leona M. and Harry B. Helmsley Charitable Trust
Juvenile Diabetes Research Foundation United States of America
Received: 21 November 2018
Accepted: 10 April 2020
First Online: 7 May 2020
: Q.P.P., A.V., and D.A.M are all inventors on patent applications for content described in this manuscript. D.M. is a founder of Semma Therapeutics and equity holder of Semma/Vertex. Semma/Vertex has licensed technology developed in D.M.’s lab. L.C., B.T., and M.S.W. are employees at AstraZeneca. The remaining authors declare no competing interests.